Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU devices industry disadvantaged in rare disease niche

This article was originally published in Clinica

Executive Summary

Eucomed, the European medical devices industry association, has highlighted the fact that the EU medical devices sector does not benefit from the same incentives as the pharmaceutical sector in terms of investment programmes for products aimed at diagnosing and treating rare diseases, nor as the medical devices industry in the US. The result of this is that patients in the EU whose rare conditions can only be effectively treated with medical devices are being discriminated against compared with those whose rare conditions can be treated with pharmaceuticals or who are being treated in the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063460

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel